$BNTX up about 9% on the FTD news though that doesnt seem really newsworthy. The PR does mention that BNT162b1 &amp; BNT162b2 as being "most advanced" and that P1/2 data + animal data provided to FDA. Both prime+boost $PFE $MRNA $NVAX